Shares in Novo Nordisk plunged 20% on Friday. Read More Source link
Home/Money/Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints Money Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints Oklahoma Digital NewsDecember 20, 2024 Less than a minute Shares in Novo Nordisk plunged 20% on Friday. Read More Source link Oklahoma Digital NewsDecember 20, 2024 Less than a minute
